Abstract
AbstractWe describe two patients with parkinsonism and depressive symptoms who experienced a worsening of their motor disturbances following use of fluvoxamine, a serotonin selective reuptake inhibitor. The possible role of this drug in causing these adverse effects is discussed in the light of the complex serotonin‐dopamine interactions in the brain.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Human Psychopharmacology: Clinical and Experimental
Paper Title
Journal
Date
